The approval gives NSCLC patients whose tumours carry the MET exon 14 skipping mutation a new treatment option
Author: Clinical Editor
RBX2660 may bring an innovative therapeutic option to patients suffering from C. diff
The news on cardiopulmonary resuscitation (CPR) in covid-191 is the latest example of the state of confusion, denial, […]
The UK’s death toll from covid-19 has exceeded 32 000, making it the worst affected country in Europe, […]
A High Court judge has ruled that an elderly woman with terminal cancer should be released immediately from […]
Guidelines that advise doctors to manage common infant symptoms as cow’s milk allergy are not evidence based and […]
Researchers have announced the isolation and characterization of a unique antibody that can bind to the virus that […]
AstraZeneca has watched superstar SGLT2 diabetes med Farxiga nail trial after trial in highly coveted kidney and heart failure […]
German drugmaker Fresenius Kabi has made major investments in its U.S. manufacturing operations in recent years with some […]
Individuals with an underactive bladder, for example following a spinal cord injury, often cannot sense bladder fullness or […]